News
Filters
Showing 21 - 30 out of 37 results
Article
KCUR: How to Talk to Children about Shooting at Kansas City Chiefs Super Bowl Rally
A licensed professional counselor from Saint Luke’s Crittenton Children’s Center talked with Steve Kraske on Up To Date at KCUR about how adults can talk to children about this tragic event.
Article
KMBC: How to Talk to Children after Shooting at Kansas City Chiefs Super Bowl Rally
A licensed professional counselor from Saint Luke’s Crittenton Children’s Center talked with KMBC about how adults can talk to children about this tragic event and signs that a child may need some extra help processing the trauma.
KSHB: How to Talk to Children about the Tragic Shooting at Kansas City Chiefs Super Bowl Rally
A licensed professional counselor from Saint Luke’s Crittenton Children’s Center talked with KSHB about how adults can talk to children about this tragic event.
Patient Stories
FOX4: Lifelong Chiefs Fan, Heart Transplant Recipient Going to Super Bowl LVIII
FOX4 talked to Ted Perez and his heart transplant surgeon, Dr. Russ Davis, about the lifelong Chiefs fan's incredible story.
News
FDA Approves PulseSelect Pulsed Field Ablation System, a Novel Treatment for Atrial Fibrillation
Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.
News
FOX4: Columbia Man Receives Saint Luke's 1,000th Heart Transplant
A man from Columbia, Missouri, got a new heart and a second chance at life, marking the 1,000th heart transplant at Saint Luke's Mid America Heart Institute.
News
CBS Evening News: Study Shows Wegovy May Reduce Risk of Heart Failure
The study shows that the diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.
News
Good Morning America: New Study Highlights Benefits to Weight Loss Drugs
Semaglutide, the active ingredient on weight loss drugs Wegovy and Ozempic, shows evidence that the drug may also help reduce the risks of heart disease.
News
CNN: Weight-Loss Drug Wegovy Produces ‘Largest Benefit Ever Seen’ for Patients with Most Common Form of Heart Failure, Trial Finds
The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.
Article
U.S. News & World Report: Wegovy May Be Valuable New Option for Heart Failure Patients
Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.